Antiprotozoal Drug (PLUS | 2024)

Antiprotozoal drugs are a class of medications specifically designed to treat infections caused by protozoa—single-celled eukaryotic organisms. These drugs are critical for managing diseases that primarily affect tropical and subtropical regions, impacting over annually. Market and Clinical Landscape

The global antiprotozoal drugs market is experiencing significant growth, driven by the rising burden of diseases like malaria and leishmaniasis. antiprotozoal drug

Malaria remains the most prevalent, with an estimated 249 million cases in 2022. Other major targets include Chagas disease, leishmaniasis, giardiasis, and trichomoniasis. Antiprotozoal drugs are a class of medications specifically

Over 60% of prescriptions are issued in lower-middle-income economies, with India and China manufacturing roughly 72% of the global generic supply for key drugs like metronidazole. Common Drugs and Their Applications Malaria remains the most prevalent, with an estimated

Compounds such as Metronidazole , Atovaquone, and Benznidazole continue to lead treatment protocols.

Antiprotozoals are often categorized into and other antiprotozoal drugs .